Vascular CXCR4 Expression – a Novel Antiangiogenic Target in Gastric Cancer?

• Barbara Ingold ,

  Contributed equally to this work with: Barbara Ingold, Eva Simon

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯
• Eva Simon ,

  Contributed equally to this work with: Barbara Ingold, Eva Simon

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯
• Ute Ungethüm,

  Affiliation Laboratory of Functional Genomics, Charité University Hospital, Berlin, Germany

  ⨯
• Ralf-Jürgen Kuban,

  Affiliation Laboratory of Functional Genomics, Charité University Hospital, Berlin, Germany

  ⨯
• Berit M. Müller,

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯
• Amelie Lupp,

  Affiliation Institute of Pharmacology and Toxicology, Friedrich-Schiller-University, Jena, Germany

  ⨯
• Ulf Neumann,

  Affiliation Department of General, Visceral and Transplantation Surgery, Campus Virchow, Charité University Hospital, Berlin, Germany

  ⨯
• Matthias P. A. Ebert,

  Affiliation Department of Medicine II, Klinikum rechts der Isar, Technical University, Munich, Germany

  ⨯
• Carsten Denkert,

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯
• Wilko Weichert,

  Current address: Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯
• Stefan Schulz,

  Affiliation Institute of Pharmacology and Toxicology, Friedrich-Schiller-University, Jena, Germany

  ⨯
• Christoph Röcken

  * E-mail: christoph.roecken@uk-sh.de

  Current address: Institute of Pathology, Christian-Albrechts-University, Kiel, Germany

  Affiliation Institute of Pathology Campus Mitte, Charité University Hospital, Berlin, Germany

  ⨯